Vetter Pharma-Fertigung GmbH & Co. KG will inject the International Contract Service Expo (ICSE) with a calibrated dose of knowledge and leadership in the field of aseptically pre-filled product solutions.

One of the world's leading providers of aseptically pre-filled injection systems, Vetter will exhibit at booth No. 41J41, Hall 4.1, at the 2008 ICSE show to be held Sept. 30 to Oct. 2 in Frankfurt, Germany.

In addition, Dr. Hermann Piana, one of Vetter's key account managers, will discuss the critical need for competence in calibrating packaging as well as the role it plays in developing, launching and managing a pre-packaged product successfully.

Titled "Successful Lifecycle Management of a Sterile Drug Product," Dr. Piana's presentation will be given three separate times as part of the ICSE Speaker's Corner. His lecture is scheduled to take place from 11 a.m. to 11:25 a.m. on all three days of the ICSE event.

"Calibrating a drug with its packaging is one of the most critical challenges in aseptic filling today," Dr. Piana said.

"Increasingly complex substances are making more and more demands on the composition of injection systems. Regulatory authorities around the world also keep making safety laws more stringent, and drug manufacturers and users alike are calling for more patient-friendly application systems," he said.

"The challenge is particularly prevalent with highly complex biotech substances because bio-pharmaceutically manufactured drugs are extremely sensitive to their environment. All materials that are used—the type of glass, the various components, like the stoppers and other parts, and the degree of siliconization must be optimally matched with the respective active substances to ensure effectiveness. This is where Vetter offers a decisive core competency, and we look forward to sharing our experience with ICSE participants," Dr. Piana added.

About Vetter Pharma-Fertigung GmbH & Co. KG:
Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject dual-chamber syringe. With about 1,900 employees worldwide, Vetter holds nearly 140 patents and has longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. In 2007, the company also received the go-ahead as a foreign manufacturer for the Japanese pharmaceutical market from Japan's Ministry for Health, Labor and Welfare. Additionally, Vetter has received two awards for its new facility Ravensburg Vetter South (RVS): The Facility of the Year Award 2007 (Process Innovation category) and the European Outsourcing Award 2007 (Most Improved Process/Plant/Facility category).

Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world.